WORCESTER, Mass.--(BUSINESS WIRE)--Dr. John E. Ware, Jr., Chief Science Officer and Founder of John Ware Research Group, Inc. (JWRG), a leading health outcomes company, is elected a Charter Fellow of the National Academy of Inventors (NAI). The NAI recognizes inventors who hold U.S. patents. Nominated by the University of Massachusetts Medical School where Dr. Ware is also Professor and Chief of the Outcomes Measurement Sciences Division, Dr. Ware said, "it is an honor to be an NAI Charter Fellow and to be in the company of such distinguished innovators." Dr. Ware, holder of numerous awards, is a globally recognized inventor of the patient reported outcomes (PRO) field. PROs are used in clinical trials and healthcare, including medical practice and electronic health records. PROs measure treatment outcomes, now at the forefront of healthcare reform.
The newly elected NAI class of Fellows is comprised of inventors and innovators from 56 global research universities and non-profit research institutes who, collectively, hold over 3,200 U.S. patents. Included among the Fellows are eight Nobel Laureates, 14 presidents of research universities and non-profit research institutes. Dr. Ware is one of 53 members from the National Academies (National Academy of Sciences, National Academy of Engineering, Institute of Medicine), 11 inductees of the National Inventors Hall of Fame, two Fellows of the Royal Society, five recipients of the National Medal of Technology and Innovation, four recipients of the National Medal of Science, and 31 AAAS Fellows.
Dr. Ware's first patent brought computer adaptive testing (CAT) to the PRO field for which he is a global thought leader. CAT made it practical to quantify the voice of the patient in clinical trials and in healthcare before and after treatments. This advance has been adopted by the National Institutes of Health (NIH) as the standard for more practical health measurement in the Patient Reported Outcomes Management Information System (PROMIS®) for which Dr. Ware is a collaborator.
Dr. Ware's second patent (pending) is for inventing a more comprehensive Quality of Life Information System (QOLIX®) which integrates disease-specific and generic PROs using an adaptive survey logic (ASLX®), a breakthrough in administering briefer surveys which produce more useful and interpretable data in real-time to clinicians, study sponsors, and patients.